Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $17.8 Million - $20.8 Million
-80,309 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $422,590 - $503,229
-1,953 Reduced 2.37%
80,309 $18.5 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $403,363 - $448,573
-1,719 Reduced 2.05%
82,262 $20.9 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $157,258 - $192,978
-795 Reduced 0.94%
83,981 $19.8 Million
Q4 2019

Feb 19, 2020

SELL
$189.21 - $243.2 $125,257 - $160,998
-662 Reduced 0.77%
84,776 $20.4 Million
Q3 2019

Nov 05, 2019

SELL
$174.11 - $208.62 $269,696 - $323,152
-1,549 Reduced 1.78%
85,438 $16.5 Million
Q2 2019

Aug 12, 2019

SELL
$166.7 - $195.41 $298,226 - $349,588
-1,789 Reduced 2.02%
86,987 $16 Million
Q1 2019

May 07, 2019

SELL
$180.87 - $203.88 $192,264 - $216,724
-1,063 Reduced 1.18%
88,776 $16.9 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $205,873 - $240,320
-1,154 Reduced 1.27%
89,839 $17.5 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $453,775 - $511,571
-2,449 Reduced 2.62%
90,993 $18.9 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $54,298 - $60,988
327 Added 0.35%
93,442 $17.2 Million
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $1.36 Million - $1.58 Million
-7,998 Reduced 7.91%
93,115 $15.9 Million
Q4 2017

Feb 14, 2018

SELL
$168.79 - $188.59 $30,213 - $33,757
-179 Reduced 0.18%
101,113 $17.6 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $16.9 Million - $19.3 Million
101,292
101,292 $18.9 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mason Street Advisors, LLC Portfolio

Follow Mason Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mason Street Advisors, LLC with notifications on news.